NanoViricides, Inc. (NNVC)

USD 1.5

(0.67%)

Annual Income Statements

(In USD)
Breakdown 2024 2023 2022 2021 2020 2019
Revenue - - - - - -
Cost of Revenue 759.01 Thousand 747.52 Thousand 723.32 Thousand 704.53 Thousand 699.72 Thousand 695.91 Thousand
Gross Profit -759.01 Thousand -747.52 Thousand -723.32 Thousand -704.53 Thousand -699.72 Thousand -695.91 Thousand
Operating Expenses 8.51 Million 8.94 Million 8.11 Million 8.74 Million 7.99 Million 8.65 Million
Selling, General and Administrative Expenses 3.07 Million 2.55 Million 2.32 Million 2.62 Million 3.3 Million 2.73 Million
Research and Development Expenses 5.43 Million 6.39 Million 5.78 Million 6.11 Million 4.69 Million 5.92 Million
Other Expenses - - - - -142.66 Thousand -
Cost and Expenses 8.51 Million 8.94 Million 8.11 Million 8.74 Million 7.99 Million 8.65 Million
Operating Income -8.51 Million -8.94 Million -8.11 Million -8.74 Million -7.99 Million -8.65 Million
Interest Expense - 938.00 5123.00 85.4 Thousand 93.67 Thousand -
Income Tax Expense - 355.83 Thousand -6736.00 85.4 Thousand -48.99 Thousand -179.74 Thousand
Earnings before Tax -8.29 Million -8.58 Million -8.1 Million -8.82 Million -13.44 Million -8.42 Million
Net Income -8.29 Million -8.58 Million -8.1 Million -8.9 Million -13.39 Million -8.24 Million
Earnings Per Share Basic -0.70 -0.74 -0.70 -0.82 -2.39 -2.30
Earnings Per Share Diluted -0.70 -0.74 -0.70 -0.82 -2.39 -2.30
Weighted Average Shares Outstanding 11.87 Million 11.62 Million 11.53 Million 10.9 Million 5.61 Million 3.59 Million
Weighted Average Shares Outstanding (Diluted) 11.87 Million 11.62 Million 11.53 Million 10.9 Million 5.61 Million 3.59 Million
Gross Margin - - - - - -
EBIT Margin - - - - - -
Profit Margin - - - - - -
EBITDA -7.75 Million -7.84 Million -7.37 Million -8.03 Million -7.29 Million -7.96 Million
Earnings Before Tax Margin - - - - - -

Income Statement Charts